Comments on: European Regulators And Their Conflicts Of Interest http://www.pharmalot.com/2009/11/european-regulators-and-their-conflicts-of-interest/ News, Comment and Conversation Fri, 10 Feb 2012 21:43:49 +0000 http://wordpress.org/?v=2.6.2 By: patrons99 http://www.pharmalot.com/2009/11/european-regulators-and-their-conflicts-of-interest/#comment-449794 patrons99 Sun, 06 Dec 2009 18:13:00 +0000 http://www.pharmalot.com/?p=20122#comment-449794 It appears that Astra Zeneca and Glaxo SmithKline played an active role in doing away with placebo controlled studies in Europe. Choice of Control in Clinical Trials - Issues and Implications of ICH-E10 http://www.efspi.org/PDF/publications/position_papers/E1202.pdf Guideline on the Choice of the Non-Inferiority Margin http://www.emea.europa.eu/pdfs/human/ewp/215899en.pdf It appears that Astra Zeneca and Glaxo SmithKline played an active role in doing away with placebo controlled studies in Europe.

Choice of Control in Clinical Trials - Issues and Implications of ICH-E10

http://www.efspi.org/PDF/publications/position_papers/E1202.pdf

Guideline on the Choice of the Non-Inferiority Margin

http://www.emea.europa.eu/pdfs/human/ewp/215899en.pdf

]]> By: patrons99 http://www.pharmalot.com/2009/11/european-regulators-and-their-conflicts-of-interest/#comment-449789 patrons99 Sun, 06 Dec 2009 17:43:04 +0000 http://www.pharmalot.com/?p=20122#comment-449789 The U.S. certainly does not have the market cornered when it comes to COI's in drug development and drug marketing. Pharma is a multinational syndicate/consortium/cartel. Their influence and presence is worldwide. It's a global problem. The U.S. certainly does not have the market cornered when it comes to COI’s in drug development and drug marketing. Pharma is a multinational syndicate/consortium/cartel. Their influence and presence is worldwide. It’s a global problem.

]]>